Zemplar

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication helps regulate calcium and phosphorus levels. It is suitable for patients on dialysis or with early-stage kidney issues. Always follow healthcare provider guidance when using paricalcitol.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease. It helps reduce elevated parathyroid hormone levels, which can impact bone health. The medication is often prescribed when phosphate binders and diet adjustments are insufficient. It may also be used in patients not yet on dialysis to manage early-stage kidney-related parathyroid issues.

Paricalcitol works by mimicking the action of vitamin D, helping the body absorb calcium and reduce parathyroid hormone production. Patients may notice improved energy levels or reduced bone discomfort over time. Some individuals report mild gastrointestinal effects like nausea or constipation during the initial weeks of treatment.

Store paricalcitol at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Inform your healthcare provider about any current medications or supplements before starting paricalcitol. Regular blood tests may be required to monitor calcium, phosphorus, and parathyroid hormone levels.

Paricalcitol may interact with other vitamin D supplements, calcium-based medications, or phosphate binders. Certain anticonvulsants, steroids, or cholesterol-lowering drugs can affect how paricalcitol works. Avoid taking magnesium-containing antacids or laxatives without medical advice. Alcohol and grapefruit products may also influence its effectiveness.